Evaluating The Potential Impact Of Aurobindo’s Unbundling

17 Dec 2011
View Resource

Examination of the potential benefit, if any, of Aurobindo’s decision to opt out of the MPP-Gilead license for TDF.

Next resource:

I-MAK & AELP: The Costs of Pharma Cheating

 View All resources

Partner with us now to build
a more just and equitable
medicine system for all.